ASK REDCHAT ANYTHING ABOUT KORRO BIO INC.
Korro Bio Inc. (NASDAQ: KRRO)
Listen to this Section
$10.60
-0.5800
(
-5.19% )
111.2K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| KRRO-110DetailsAlpha-1 Antitrypsin Deficiency |
Phase 1/2 |
| FX-322DetailsEar disease, Sensorineural hearing loss |
Failed |
| FX-345DetailsSensorineural hearing loss, Ear disease |
Failed |
Market Data
|
| Open |
$10.60 |
| Previous Close |
$11.18 |
| Volume |
111.2K |
| Market Cap |
$159.80M |
| Day Range |
$10.51 - $11.36 |
| 52 Week Range |
$5.20 - $55.89 |
| Shares Outstanding |
14.42M |
| Change % |
-5.19% |
| Net Change |
▼ -0.5800 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2023 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-2,193,413.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-11-07 |
Sale |
-942075.00 |
FORMELA JEAN FRANCOIS |
| 2023-08-22 |
Sale |
-227.00 |
Mitrano Richard J. |
| 2023-08-22 |
Sale |
-2865.00 |
Lucchino David L. |
| 2023-08-18 |
Sale |
-234.00 |
Mitrano Richard J. |
| 2023-08-18 |
Sale |
-2895.00 |
Lucchino David L. |
| 2023-08-16 |
Sale |
-238.00 |
Mitrano Richard J. |
| 2023-08-16 |
Sale |
-2881.00 |
Lucchino David L. |
| 2023-08-14 |
Sale |
-247.00 |
Mitrano Richard J. |
| 2023-08-14 |
Sale |
-2790.00 |
Lucchino David L. |
| 2023-08-10 |
Sale |
-2810.00 |
Lucchino David L. |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| schedule |
Other |
1 |
Nov 14, 2025 |
| 8-k |
8K-related |
12 |
Nov 12, 2025 |
| 10-q |
Quarterly Reports |
80 |
Nov 12, 2025 |
| 8-k |
8K-related |
11 |
Oct 08, 2025 |
| 8-k |
8K-related |
12 |
Aug 12, 2025 |
| 10-q |
Quarterly Reports |
77 |
Aug 12, 2025 |
| 8-k/a |
8K-related |
10 |
Jun 18, 2025 |
| 4 |
Insider transactions |
2 |
Jun 12, 2025 |
| 4 |
Insider transactions |
2 |
Jun 12, 2025 |
| 4 |
Insider transactions |
2 |
Jun 12, 2025 |